Login / Signup

Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer.

Frances WillenbrockCatrin M CoxEileen E ParkesCharlotte S Wilhelm-BenartziAswin G AbrahamRobert OwensAhmad SabbaghChristopher M JonesDaniel L I HughesTim MaughanChristopher N HurtEric E O'NeillSomnath Mukherjee
Published in: British journal of cancer (2020)
The SCALOP trial was registered with ISRCTN, number 96169987 (registered 29 May 2008).
Keyphrases
  • locally advanced
  • phase iii
  • clinical trial
  • open label
  • study protocol
  • rectal cancer
  • phase ii study
  • squamous cell carcinoma
  • phase ii
  • double blind
  • radiation therapy
  • placebo controlled
  • randomized controlled trial